Methods and apparatus for monitoring and quantifying the movement of fluid
View Patent ↗Methods, systems and devices are provided for monitoring and quantifying the movement of fluid in a target region. Generally, an imaging agent is introduced into a target region through fluid flow. The imaging agent in the target region is then disrupted using appropriate methods such as the application of ultrasonic energy. As fluid flow brings undisrupted imaging agent into the target region, the rate of accumulation is monitored and quantified thereby providing the exchange rate and flow rate of the fluid in the target region. The disclosed invention is particularly useful for medical applications such as determining the flow rate of blood in an organ or tissue.
1. A method for determining an exchange rate for a moving fluid in a target region comprising the steps of:
introducing undisrupted imaging agent into a moving fluid, said moving fluid being present in a target region;
allowing undisrupted imaging agent to penetrate said target region;
disrupting the imaging agent in the target region to provide disrupted imaging agent having a signal level less than that provided by undisrupted imaging agent;
allowing the moving fluid to transport undisrupted imaging agent from outside the target region into the target region;
interrogating the target region with a monitor capable of registering the signal level whereby an increase in signal level corresponding to an increase in undisrupted imaging agent is observed;
calculating the exchange rate of moving fluid in the target region based on the observed increase in signal level;
comparing the exchange rate of moving fluid in the target region based on the observed increase in signal levels are measured at different times to ascertain the increase in signal per unit time;
dividing the increase in signal per unit time by a measured or derived maximum signal value to obtain the fluid exchange rate, and,
multiplying the obtained fluid rate exchange rate by the fluid content of said target region to obtain a perfusion rate for said target region.
2. The method of claim 1 wherein said target region comprises mammalian tissue.
3. The method of claim 1 wherein said target region comprises at least a portion of a mammalian organ.
4. The method of claim 1 wherein said imaging agent comprises a composition selected from the group consisting of ultrasound contrast agents and magnetic resonance imaging agents.
5. The method of claim 1 wherein said imaging agent comprises a microbubble contrast agent.
6. The method of claim 5 wherein said microbubble contrast agent comprises a fluorocarbon gas or vapor.
7. The method of claim 6 wherein said fluorocarbon gas or vapor is selected from the group consisting of fluoroheptane, fluorocycloheptane fluoromethylcycloheptane, fluorohexane, fluorocyclohexane, fluoropentane, fluorocyclopentane, fluoromethylcyclopentane, fluorodimethylcyclopentanes, fluoromethylcyclobutane, fluorodimethylcyclobutane, fluorotrimethylcyclobutane, fluorobutane, fluorocyclobutane, fluoropropane, fluoroethers, fluoropolyethers, fluorotriethylamines and combinations thereof.
8. The method of claim 7 wherein said fluorocarbon gas or vapor is perflucropentane.
9. The method of claim 7 wherein said fluorocarbon gas or vapor is perfluorohexane.
10. The method of claim 1 , wherein said interrogating step comprises emitting at least one ultrasonic pulse to measure one or more signal levels indicative of the concentration of intact microbubbles in said target region.
11. The method of claim 10 wherein said imaging agent comprises a microbubble contrast agent.
12. The method of claim 11 wherein said niicrobubble contrast agent comprises a fluorocarbon gas or vapor.
13. The method of claim 12 wherein said fluorocarbon gas or vapor is selected from the group consisting of fluoroheptane, fluorocycloheptane fluoromethylcycloheptane, fluorohexane, fluorocyclohexane, fluoropentane, fluorocyclopentane, fluoromethylcyclopentane, fluorodimethylcyclopentanes, fluoromethylcyclobutane, fluorodimethylcyclobutane, fluorotrimethylcyclobutane, fluorobutane, fluorocyclobutane, fluoropropane, fluoroethers, fluoropolyethers, fluorotriethylamines and combinations thereof.
14. The method of claim 10 , wherein said signal levels are measured using a frequency different from the frequency of the emitted ultrasonic pulse.
15. The method of claim 10 , wherein a plurality of ultrasonic pulses are used to measure signal levels indicative of the level of intact microbubbles in said target region.
16. The method of claim 10 , wherein said disrupting step comprises applying ultrasonic energy at a power level sufficient to destroy a portion of the microbubbles.
17. The method of claim 16 wherein said disrupting step and said interrogating step use equivalent ultrasonic power levels.
18. The method of claim 16 , wherein there is an unsonicated interval between the termination of said disruptive ultrasonic energy and said at least one ultrasonic interrogative pulse.
19. The method of claim 1 wherein said interrogating step comprises the use of magnetic resonance imaging.
20. The method of claim 1 wherein said calculating step comprises:
comparing at least two signal levels indicative of the concentration of intact imaging agent in said target region wherein the signal levels are measured at different times to ascertain the increase in signal per unit time;
dividing the increase in signal per unit time by a measured or derived maximum signal value to obtain the fluid exchange rate;
multiplying the obtained fluid exchange rate by the fluid content of said target region to obtain a perfusion rate for said target region.